Doyle Janeen Noel
- SEC CIK
- 0002069239
In the past year, 1 open-market sale filing worth $56.9K and no purchases.
Current role at each company
- JANX Janux Therapeutics, Inc.Chief Corp. & Bus. Dev. Ofcras of Jun 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $56.9K
- 1 filing
- Net
- −$56.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Doyle Janeen Noel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 (view filing) | Jun 2 | 2 days | Doyle Janeen NoelChief Corp. & Bus. Dev. Ofcr | SSale | −4.06K | $14.03 | −$56.9K | −5.1%75.9K after |